MNPR
USDMonopar Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$85.950
Максимум
$86.140
Минимум
$80.105
Объем
0.14M
Фундаментальные показатели компании
Рыночная капитализация
510.3M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.07M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Barclays Initiates Coverage On Monopar Therapeutics with Overweight Rating, Announces Price Target of $125
Barclays analyst Etzer Darout initiates coverage on Monopar Therapeutics with a Overweight rating and announces Price Target of $125.
Raymond James Maintains Strong Buy on Monopar Therapeutics, Raises Price Target to $142
Raymond James analyst Chris Raymond maintains Monopar Therapeutics with a Strong Buy and raises the price target from $80 to $142.
HC Wainwright & Co. Maintains Buy on Monopar Therapeutics, Raises Price Target to $105
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Monopar Therapeutics with a Buy and raises the price target from $70 to $105.
Piper Sandler Maintains Overweight on Monopar Therapeutics, Raises Price Target to $95
Piper Sandler analyst Biren Amin maintains Monopar Therapeutics with a Overweight and raises the price target from $76 to $95.
Chardan Capital Maintains Buy on Monopar Therapeutics, Raises Price Target to $85
Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics with a Buy and raises the price target from $60 to $85.
BTIG Maintains Buy on Monopar Therapeutics, Raises Price Target to $104
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics with a Buy and raises the price target from $87 to $104.
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar Therapeutics", "Monopar", or the "Company"), a clinical-stage biopharmaceutical company developing innovative
Связанные акции
BHFAL
Brighthouse Financial Inc. 6.25% Junior Subordinated Debentures due 2058
JHS
John Hancock Income Securities Trust
ACHL
Achilles Therapeutics plc American Depositary Shares
PDEX
Pro-Dex Inc.
HUM
Humana Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.